s'authentifier
version française rss feed
Fiche concise
TP53 status and response to treatment in breast cancers.
Varna M., Bousquet G., Plassa L.-F., Bertheau P., Janin A.
Journal of Biomedicine and Biotechnology 2011 (2011) 284584 - http://www.hal.inserm.fr/inserm-00741097
 (21760703) 
TP53 status and response to treatment in breast cancers.
Mariana Varna1, Guilhem Bousquet1, Louis-François Plassa2, Philippe Bertheau1, 3, Anne Janin () 1, 3
1 :  Gvh et Gvl : Physiopathologie Chez l'Homme et Chez l'Animal, Incidence et Role Therapeutique
INSERM : U728 – Université Paris VII - Paris Diderot
Hopital Saint-Louis - Centre Hayem PARIS VII 1, Avenue Claude Vellefaux 75475 PARIS CEDEX 10
France
2 :  Laboratoire de Biochimie
Hôpital Saint-Louis – Assistance publique - Hôpitaux de Paris (AP-HP) – Université Paris VII - Paris Diderot
1, Avenue Claude-Vellefaux - 75010 Paris
France
3 :  Service d'anatomo-pathologie
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital Saint-Louis – Université Paris VII - Paris Diderot
1 avenue Claude Vellefaux 75475 Paris cedex 10
France
The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is reported to be a factor for good prognosis in some studies, while in others it is a factor for poor prognosis. The explanation for these different results could be linked to the fact that the studies were performed on different tumor types and with different therapy regimens.
Sciences du Vivant/Cancérologie
Anglais
1110-7243

Articles dans des revues avec comité de lecture
10.1155/2011/284584
Journal of Biomedicine and Biotechnology
Publisher Hindawi Publishing Corporation
ISSN 1110-7243 (eISSN : 1110-7251)
internationale
2011
09/05/2011
2011
284584

Animals – Breast Neoplasms – Female – Genes – p53 – Humans – Mice – Mutation – Prognosis – Animals
This work was supported by grants from Canceropole Ile de France. M. Varna and G. Bousquet were equally contributed
Liste des fichiers attachés à ce document : 
PDF
284584.pdf(1.1 MB)